{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:41:57Z","timestamp":1772491317462,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12094-021-02675-w","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T08:08:16Z","timestamp":1627373296000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a National Cancer Database analysis"],"prefix":"10.1007","volume":"24","author":[{"given":"J. M.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-718X","authenticated-orcid":false,"given":"R.","family":"Kabarriti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. P.","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kalnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"issue":"12","key":"2675_CR1","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","volume":"17","author":"DS Ettinger","year":"2019","unstructured":"Ettinger DS, Wood DE, Aggarwal C, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D\u2019Amico TA, Dilling TJ, Dobelbower M, Gettinger S, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Martins RG, Otterson GA, Patel SP, Reckamp KL, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer KW, Yang SC, Gregory K, Ocn HM. NCCN Guidelines insights: non-small cell lung cancer, version 1. 2020. J Natl Compr Canc Netw. 2019;17(12):1464\u201372. https:\/\/doi.org\/10.6004\/jnccn.2019.0059.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5S","key":"2675_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.6004\/jnccn.2018.0042","volume":"16","author":"CA Barker","year":"2018","unstructured":"Barker CA, Salama AK. New NCCN guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma. J Natl Compr Canc Netw. 2018;16(5S):646\u201350. https:\/\/doi.org\/10.6004\/jnccn.2018.0042.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"2675_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archneur.1988.00520310047016","volume":"45","author":"JY Delattre","year":"1988","unstructured":"Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol. 1988;45(7):741\u20134. https:\/\/doi.org\/10.1001\/archneur.1988.00520310047016.","journal-title":"Arch Neurol"},{"issue":"11","key":"2675_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","volume":"15","author":"LB Nabors","year":"2017","unstructured":"Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Butowski N, Fenstermaker RA, Forsyth P, Hattangadi-Gluth J, Holdhoff M, Howard S, Junck L, Kaley T, Kumthekar P, Loeffler JS, Moots PL, Mrugala MM, Nagpal S, Pandey M, Parney I, Peters K, Puduvalli VK, Ragsdale J, Rockhill J, Rogers L, Rusthoven C, Shonka N, Shrieve DC, Sills AK, Swinnen LJ, Tsien C, Weiss S, Wen PY, Willmarth N, Bergman MA, Engh A. NCCN guidelines insights: central nervous system cancers, version 1. 2017. J Natl Compr Canc Netw. 2017;15(11):1331\u201345. https:\/\/doi.org\/10.6004\/jnccn.2017.0166.","journal-title":"J Natl Compr Canc Netw"},{"key":"2675_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejca.2018.12.023","volume":"110","author":"R Rauschenberg","year":"2019","unstructured":"Rauschenberg R, Bruns J, Brutting J, Daubner D, Lohaus F, Zimmer L, Forschner A, Zips D, Hassel JC, Berking C, Kaehler KC, Utikal J, Gutzmer R, Terheyden P, Meiss F, Rafei-Shamsabadi D, Kiecker F, Debus D, Dabrowski E, Arnold A, Garzarolli M, Kuske M, Beissert S, Lock S, Linn J, Troost EGC, Meier F. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases. Eur J Cancer. 2019;110:11\u201320. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.023.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2675_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2018.06.017","volume":"128","author":"P Gabani","year":"2018","unstructured":"Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes. Radiother Oncol. 2018;128(2):266\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.017.","journal-title":"Radiother Oncol"},{"key":"2675_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.radonc.2019.06.004","volume":"138","author":"JE Bates","year":"2019","unstructured":"Bates JE, Morris CG, Milano MT, Yeung AR, Hoppe BS. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: an analysis of the National Cancer Database. Radiother Oncol. 2019;138:75\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2019.06.004.","journal-title":"Radiother Oncol"},{"issue":"7","key":"2675_CR8","doi-asserted-by":"publisher","first-page":"e1511","DOI":"10.7759\/cureus.1511","volume":"9","author":"SM Nguyen","year":"2017","unstructured":"Nguyen SM, Castrellon A, Vaidis O, Johnson AE. Stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone in melanoma brain metastases. Cureus. 2017;9(7):e1511. https:\/\/doi.org\/10.7759\/cureus.1511.","journal-title":"Cureus"},{"issue":"7","key":"2675_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jso.23568","volume":"109","author":"S Mohanty","year":"2014","unstructured":"Mohanty S, Bilimoria KY. Comparing national cancer registries: the National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J Surg Oncol. 2014;109(7):629\u201330. https:\/\/doi.org\/10.1002\/jso.23568.","journal-title":"J Surg Oncol"},{"issue":"2","key":"2675_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361. https:\/\/doi.org\/10.1002\/pst.433.","journal-title":"Pharm Stat"},{"issue":"7560","key":"2675_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341. https:\/\/doi.org\/10.1038\/nature14432.","journal-title":"Nature"},{"issue":"2","key":"2675_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ni.3666","volume":"18","author":"B Engelhardt","year":"2017","unstructured":"Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18(2):123\u201331. https:\/\/doi.org\/10.1038\/ni.3666.","journal-title":"Nat Immunol"},{"issue":"7","key":"2675_CR13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","volume":"17","author":"SB Goldberg","year":"2016","unstructured":"Goldberg SB, Gettinger SN, Mahajan A, Chiang AC, Herbst RS, Sznol M, Tsiouris AJ, Cohen J, Vortmeyer A, Jilaveanu L, Yu J, Hegde U, Speaker S, Madura M, Ralabate A, Rivera A, Rowen E, Gerrish H, Yao X, Chiang V, Kluger HM. Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2016;17(7):976\u201383. https:\/\/doi.org\/10.1016\/S1470-2045(16)30053-5.","journal-title":"Lancet Oncol"},{"issue":"8","key":"2675_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1805453","volume":"379","author":"HA Tawbi","year":"2018","unstructured":"Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K. Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018;379(8):722\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1805453.","journal-title":"N Engl J Med"},{"issue":"6","key":"2675_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","volume":"41","author":"K Reynders","year":"2015","unstructured":"Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015;41(6):503\u201310. https:\/\/doi.org\/10.1016\/j.ctrv.2015.03.011.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"2675_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/annonc\/mdx790","volume":"29","author":"T Kordbacheh","year":"2018","unstructured":"Kordbacheh T, Honeychurch J, Blackhall F, Faivre-Finn C, Illidge T. Radiotherapy and anti-PD-1\/PD-L1 combinations in lung cancer: building better translational research platforms. Ann Oncol. 2018;29(2):301\u201310. https:\/\/doi.org\/10.1093\/annonc\/mdx790.","journal-title":"Ann Oncol"},{"issue":"6230","key":"2675_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69\u201374. https:\/\/doi.org\/10.1126\/science.aaa4971.","journal-title":"Science"},{"issue":"7","key":"2675_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","volume":"18","author":"N Shaverdian","year":"2017","unstructured":"Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, Garon EB, Lee P. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncol. 2017;18(7):895\u2013903. https:\/\/doi.org\/10.1016\/S1470-2045(17)30380-7.","journal-title":"Lancet Oncol"},{"issue":"10","key":"2675_CR19","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/neuonc\/nov093","volume":"17","author":"KR Patel","year":"2015","unstructured":"Patel KR, Lawson DH, Kudchadkar RR, Carthon BC, Oliver DE, Okwan-Duodu D, Ahmed R, Khan MK. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Neuro Oncol. 2015;17(10):1312\u201321. https:\/\/doi.org\/10.1093\/neuonc\/nov093.","journal-title":"Neuro Oncol"},{"issue":"1","key":"2675_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40425-019-0588-y","volume":"7","author":"G Minniti","year":"2019","unstructured":"Minniti G, Anzellini D, Reverberi C, Cappellini GCA, Marchetti L, Bianciardi F, Bozzao A, Osti M, Gentile PC, Esposito V. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. J Immunother Cancer. 2019;7(1):102. https:\/\/doi.org\/10.1186\/s40425-019-0588-y.","journal-title":"J Immunother Cancer"},{"issue":"5","key":"2675_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/nop\/npz004","volume":"6","author":"CM Lanier","year":"2019","unstructured":"Lanier CM, Hughes R, Ahmed T, LeCompte M, Masters AH, Petty WJ, Ruiz J, Triozzi P, Su J, O\u2019Neill S, Watabe K, Cramer CK, Laxton AW, Tatter SB, Wang G, Whitlow C, Chan MD. Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract. 2019;6(5):402\u20139. https:\/\/doi.org\/10.1093\/nop\/npz004.","journal-title":"Neurooncol Pract"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-021-02675-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-021-02675-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:46:39Z","timestamp":1641383199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-021-02675-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s12094-021-02675-w","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,8]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Ohri reported receiving personal fees from Merck, AstraZeneca, and Johnson & Johnson outside the submitted work. Dr Guha reported receiving grants from the National Institutes of Health and Celldex Therapeutics, grants and personal fees from Johnson & Johnson, personal fees from Varian Medical Systems, and serves on the advisory board for Focused Ultrasound Foundation outside the submitted work. The other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a retrospective study using a de-identified dataset. This study was exempt from institutional review board approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given its retrospective nature and de-identified dataset, this study was exempt from institutional review board approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}